𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ Scribed by M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouridsen

Book ID
117666048
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
117 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doxorubicin versus methotrexate both com
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group
✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

To evaluate the substitution of methotrexate with doxorubicin (Dox) in CMF-(cyclophosphamide, methotrexate, 5-fluorouracil) containing regimen for advanced breast cancer, 415 postmenopausal patients below the age of 66 years, naïve to chemotherapy, were accrued from 1980 to 1984 and followed-up unti